Health food, the blue-hat category, has required pre-market registration or filing since the dual-track system under the ...
T-MAXIMUM PHARMACEUTICAL Inc. ("T-MAXIMUM") announced that its investigational allogeneic CAR-T cell therapy MT027 has been ...
MPCi-led financing will advance Convergen’s proprietary TrimTAC degrader platform and accelerate its lead programme towards ...
It was approved by the Health Sciences Authority for the treatments of stage 1 or 2 hATTR-PN (October 2024)[3], and wild-type ...
Further the resilience of the supply chain for important medicines by donating 25 kg of tacrolimus active pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results